{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:32Z","timestamp":1792153232020,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kolfarma has partially financed this study"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We studied the effects of intestinal inflammation on pentylenetetrazole (PTZ)-induced seizures in mice and the effects thereon of some antiepileptic and anti-inflammatory treatments to establish if a link may exist. The agents tested were: alpha-lactoalbumin (ALAC), a whey protein rich in tryptophan, effective in some animal models of epilepsy and on colon\/intestine inflammation, valproic acid (VPA), an effective antiepileptic drug in this seizure model, mesalazine (MSZ) an effective aminosalicylate anti-inflammatory treatment against ulcerative colitis and sodium butyrate (NaB), a short chain fatty acid (SCFA) normally produced in the intestine by gut microbiota, important in maintaining gut health and reducing gut inflammation and oxidative stress. Intestinal inflammation was induced by dextran sulfate sodium (DSS) administration for 6 days. Drug treatment was started on day 3 and lasted 11 days, when seizure susceptibility to PTZ was measured along with intestinal inflammatory markers (\n                    <jats:italic>i.e<\/jats:italic>\n                    . NF-\u03baB, I\u03ba-B\u03b1, COX-2, iNOS), histological damage, disease activity index (DAI) and SCFA concentration in stools. DSS-induced colitis increased seizure susceptibility and while all treatments were able to reduce intestinal inflammation, only ALAC and NaB exhibited significant antiepileptic properties in mice with induced colitis, while they were ineffective as antiepileptics at the same doses in control mice without colitis. Interestingly, in DSS-treated mice, VPA lost part of its antiepileptic efficacy in comparison to preventing seizures in non-DSS-treated mice while MSZ remained ineffective in both groups. Our study demonstrates that reducing intestinal inflammation through ALAC or NaB administration has specific anticonvulsant effects in PTZ-treated mice. Furthermore, it appears that intestinal inflammation may reduce the antiepileptic effects of VPA, although we confirm that it decreases seizure threshold in this group. Therefore, we suggest that intestinal inflammation may represent a valid antiepileptic target which should also be considered as a participating factor to seizure incidence in susceptible patients and also could be relevant in reducing standard antiepileptic drug efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-50542-0","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T06:03:44Z","timestamp":1569564224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy"],"prefix":"10.1038","volume":"9","author":[{"given":"Carmen","family":"De Caro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-1476","authenticated-orcid":false,"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Constanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Citraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"50542_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani, A., Aronica, E., Mazarati, A. & Pittman, Q. J. Epilepsy and brain inflammation. Exp. Neurol. 244, 11\u201321 (2013).","journal-title":"Exp. Neurol."},{"key":"50542_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.23567","volume":"72","author":"L Librizzi","year":"2012","unstructured":"Librizzi, L., No\u00e8, F., Vezzani, A., De Curtis, M. & Ravizza, T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann. Neurol. 72, 82\u201390 (2012).","journal-title":"Ann. Neurol."},{"key":"50542_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani, A. et al. Infections, inflammation and epilepsy. Acta Neuropathol. 131, 211\u2013234 (2016).","journal-title":"Acta Neuropathol."},{"key":"50542_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nan.12444","volume":"44","author":"EA van Vliet","year":"2018","unstructured":"van Vliet, E. A., Aronica, E., Vezzani, A. & Ravizza, T. Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol. Appl. Neurobiol. 44, 91\u2013111 (2018).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"50542_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","volume":"58","author":"E Aronica","year":"2017","unstructured":"Aronica, E. et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia 58, 27\u201338 (2017).","journal-title":"Epilepsia"},{"key":"50542_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/epi.13786","volume":"58","author":"AM Mazarati","year":"2017","unstructured":"Mazarati, A. M., Lewis, M. L. & Pittman, Q. J. Neurobehavioral comorbidities of epilepsy: Role of inflammation. Epilepsia 58, 48\u201356 (2017).","journal-title":"Epilepsia"},{"key":"50542_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eplepsyres.2009.09.004","volume":"89","author":"K Riazi","year":"2010","unstructured":"Riazi, K., Galic, M. A. & Pittman, Q. J. Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability. Epilepsy Res. 89, 34\u201342 (2010).","journal-title":"Epilepsy Res."},{"key":"50542_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2017.10.010","volume":"78","author":"AWC Yuen","year":"2018","unstructured":"Yuen, A. W. C., Keezer, M. R. & Sander, J. W. Epilepsy is a neurological and a systemic disorder. Epilepsy Behav. 78, 57\u201361 (2018).","journal-title":"Epilepsy Behav."},{"key":"50542_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbi.2014.06.016","volume":"42","author":"E Russo","year":"2014","unstructured":"Russo, E. et al. Early molecular and behavioral response to lipopolysaccharide in the WAG\/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT\/mTOR pathways and neuroinflammatory cytokine release. Brain. Behav. Immun. 42, 157\u2013168 (2014).","journal-title":"Brain. Behav. Immun."},{"key":"50542_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.neuroscience.2003.08.043","volume":"122","author":"M Sayyah","year":"2003","unstructured":"Sayyah, M., Javad-Pour, M. & Ghazi-Khansari, M. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: Involvement of proinflammatory factors: Nitric oxide and prostaglandins. Neuroscience 122, 1073\u20131080 (2003).","journal-title":"Neuroscience"},{"key":"50542_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eplepsyres.2009.05.010","volume":"86","author":"S Auvin","year":"2009","unstructured":"Auvin, S. et al. Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res. 86, 124\u2013130 (2009).","journal-title":"Epilepsy Res."},{"key":"50542_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5698\/1535-7597-13.2.62","volume":"13","author":"O Devinsky","year":"2013","unstructured":"Devinsky, O., Schein, A. & Najjar, S. Epilepsy associated with systemic autoimmune disorders. Epilepsy Curr. 13, 62\u201368 (2013).","journal-title":"Epilepsy Curr."},{"key":"50542_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3748\/wjg.v20.i5.1228","volume":"20","author":"G Mor\u00eds","year":"2014","unstructured":"Mor\u00eds, G. Inflammatory bowel disease: An increased risk factor for neurologic complications. World J. Gastroenterol. 20, 1228\u20131237 (2014).","journal-title":"World J. Gastroenterol."},{"key":"50542_CR14","first-page":"8764","volume":"20","author":"G Casella","year":"2014","unstructured":"Casella, G. et al. Neurological disorders and inflammatory bowel diseases. World J. Gastroenterol. 20, 8764\u20138782 (2014).","journal-title":"World J. Gastroenterol."},{"key":"50542_CR15","doi-asserted-by":"publisher","first-page":"17151","DOI":"10.1073\/pnas.0806682105","volume":"105","author":"K Riazi","year":"2008","unstructured":"Riazi, K. et al. Microglial activation and TNF production mediate altered CNS excitability following peripheral inflammation. Proc. Natl. Acad. Sci. 105, 17151\u201317156 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"50542_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/ajcn\/42.6.1299","volume":"42","author":"B Lonnerdal","year":"1985","unstructured":"Lonnerdal, B. Biochemistry and physiological function of human milk proteins. Am. J. Clin. Nutr. 42, 1299\u20131317 (1985).","journal-title":"Am. J. Clin. Nutr."},{"key":"50542_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2011.02.013","volume":"95","author":"R Citraro","year":"2011","unstructured":"Citraro, R. et al. Preclinical activity profile of \u03b1-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res. 95, 60\u201369 (2011).","journal-title":"Epilepsy Res."},{"key":"50542_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuroscience.2012.09.021","volume":"226","author":"E Russo","year":"2012","unstructured":"Russo, E. et al. Protective activity of \u03b1-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience 226, 282\u2013288 (2012).","journal-title":"Neuroscience"},{"key":"50542_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.mehy.2007.06.039","volume":"70","author":"P Mainardi","year":"2008","unstructured":"Mainardi, P., Leonardi, A. & Albano, C. Potentiation of brain serotonin activity may inhibit seizures, especially in drug-resistant epilepsy. Med. Hypotheses 70, 876\u2013879 (2008).","journal-title":"Med. Hypotheses"},{"key":"50542_CR20","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/mds.23908","volume":"26","author":"L Errichiello","year":"2011","unstructured":"Errichiello, L. et al. A proof-of-concept trial of the whey protein alfa-lactalbumin in chronic cortical myoclonus. Mov. Disord. 26, 2573\u20132575 (2011).","journal-title":"Mov. Disord."},{"key":"50542_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/09168451.2014.890034","volume":"78","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi, M., Takai, S., Hosono, A. & Seki, T. Bovine milk-derived \u03b1-lactalbumin inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sodium sulfate-treated mice. Biosci. Biotechnol. Biochem. 78, 672\u2013679 (2014).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"50542_CR22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/bph.13637","volume":"174","author":"R Simeoli","year":"2017","unstructured":"Simeoli, R. et al. An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis. Br. J. Pharmacol. 174, 1484\u20131496 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"50542_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yebeh.2016.01.032","volume":"57","author":"K T\u00f6llner","year":"2016","unstructured":"T\u00f6llner, K., Twele, F. & L\u00f6scher, W. Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures. Epilepsy Behav. 57, 95\u2013104 (2016).","journal-title":"Epilepsy Behav."},{"key":"50542_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3892\/etm.2017.4778","volume":"14","author":"H Zhang","year":"2017","unstructured":"Zhang, H. & Chen, W. Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis. Exp. Ther. Med. 14, 2271\u20132276 (2017).","journal-title":"Exp. Ther. Med."},{"key":"50542_CR25","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.2174\/1381612823666171024130001","volume":"23","author":"R Citraro","year":"2018","unstructured":"Citraro, R. et al. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis. Curr. Pharm. Des. 23, 5546\u20135562 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"50542_CR26","first-page":"jpet.117.244939","volume":"364","author":"SD Reddy","year":"2017","unstructured":"Reddy, S. D., Clossen, B. C. & Reddy, D. S. Epigenetic Histone Deacetylation Inhibition Prevents the Development and Persistence of Temporal Lobe Epilepsy. J. Pharmacol. Exp. Ther. 364, jpet.117.244939 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"50542_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","volume":"51","author":"C Lee","year":"2017","unstructured":"Lee, C. et al. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int. Immunopharmacol. 51, 47\u201356 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"50542_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","volume":"99","author":"RM Stilling","year":"2016","unstructured":"Stilling, R. M. et al. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem. Int. 99, 110\u2013132 (2016).","journal-title":"Neurochem. Int."},{"key":"50542_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.pbb.2006.11.016","volume":"85","author":"G De Luca","year":"2006","unstructured":"De Luca, G. et al. Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS\u2212\/\u2212) before and after pentylenetetrazole kindling. Pharmacol. Biochem. Behav. 85, 804\u2013812 (2006).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"50542_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.pbb.2004.01.012","volume":"77","author":"G De Sarro","year":"2004","unstructured":"De Sarro, G. et al. Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol. Biochem. Behav. 77, 761\u2013766 (2004).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"50542_CR31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091\u20131103 (2009).","journal-title":"Gut"},{"key":"50542_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u039aB pathway dependent of HDAC3. J. Neuroinflammation 15, 150 (2018).","journal-title":"J. Neuroinflammation"},{"key":"50542_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/epi.12473","volume":"55","author":"H Dambach","year":"2014","unstructured":"Dambach, H. et al. Glia and epilepsy: Experimental investigation of antiepileptic drugs in an astroglia\/microglia co-culture model of inflammation. Epilepsia 55, 184\u2013192 (2014).","journal-title":"Epilepsia"},{"key":"50542_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s10753-017-0574-9","volume":"40","author":"MA Amirzargar","year":"2017","unstructured":"Amirzargar, M. A. et al. Anti-inflammatory Effects of Valproic Acid in a Rat Model of Renal Ischemia\/Reperfusion Injury: Alteration in Cytokine Profile. Inflammation 40, 1310\u20131318 (2017).","journal-title":"Inflammation"},{"key":"50542_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.112","volume":"7","author":"JC Zhang","year":"2017","unstructured":"Zhang, J. C. et al. Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis. Transl. Psychiatry 7, e1138 (2017).","journal-title":"Transl. Psychiatry"},{"key":"50542_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/mp.2016.46","volume":"21","author":"ML Wong","year":"2016","unstructured":"Wong, M. L. et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol. Psychiatry 21, 797\u2013805 (2016).","journal-title":"Mol. Psychiatry"},{"key":"50542_CR37","unstructured":"Pujia, A. M. et al. The probiotics in dentistry: a narrative review. Eur. Rev. Med. Pharmacol. Sci (2017)."},{"key":"50542_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/epi4.12114","volume":"3","author":"J-S Medel-Matus","year":"2018","unstructured":"Medel-Matus, J.-S., Shin, D., Dorfman, E., Sankar, R. & Mazarati, A. Facilitation of kindling epileptogenesis by chronic stress may be mediated by intestinal microbiome. Epilepsia Open 3, 290\u2013294 (2018).","journal-title":"Epilepsia Open"},{"key":"50542_CR39","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","volume":"173","author":"CA Olson","year":"2018","unstructured":"Olson, C. A. et al. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell 173, 1728\u20131741.e13 (2018).","journal-title":"Cell"},{"key":"50542_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.eplepsyres.2018.06.015","volume":"145","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Res. 145, 163\u2013168 (2018).","journal-title":"Epilepsy Res."},{"key":"50542_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/jobm.201500726","volume":"56","author":"PM Munyaka","year":"2016","unstructured":"Munyaka, P. M., Rabbi, M. F., Khafipour, E. & Ghia, J. E. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J. Basic Microbiol. 56, 986\u2013998 (2016).","journal-title":"J. Basic Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50542-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:59:50Z","timestamp":1671267590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50542-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50542-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rita Citraro has received research funding from Kolfarma Srl. Paolo Mainardi is an employee of Kolfarma Srl. Pasquale Striano has received research grants or compensation from GW pharma (UK) and Kolfarma, Eisai pharma. Emilio Russo has received research grants or compensation from Eisai pharma. All other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13983"}}